Summary
- Current Price
- As of today, ACTU price is $2.05, down -1.44% in the most recent trading session on
- Current Price All-Time High
- ACTU price is currently -82.90% below its historical high of $11.99 set on
- Market Cap
- ACTU current market cap is $49M, down -76.35% year-over-year
- PE Ratio
- ACTU PE ratio is unknown
- Revenue
- ACTU current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ACTU is on
Profile
| Metric | Value |
|---|---|
| Full Name | Actuate Therapeutics, Inc. Common stock |
| Ticker | NASDAQ: ACTU |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | actuatetherapeutics.com |
| Employees | 10 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.05 | ||
| Price, 1D Change | -1.44% | |
| $49M | ||
| - | ||
| - | ||
| 2.17 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.06 | ||
| EPS, 1Y Change | +24.31% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.06 | ||
| EPS Estimate | N/A | -$0.78 |
| EPS Est. Change | N/A | +26.55% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $2.05 | ||
| Price Target | - | $10.00 |
| Price Tgt. Change | - | +387.80% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.16 | -$1.40 | +55.79% | |
| -$1.09 | -$1.06 | +2.99% | |
| -$0.78 | N/A | +26.55% | |
| -$0.85 | N/A | +19.61% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -80.61% | ||
| - | ||
| -76.35% | ||
| - | ||
| 0.00% | ||
| 0.00% | ||
| +24.31% | ||
| -0.25% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $2.05 | ||
| $5.31 | ||
| SMA 200 vs Price | +158.98% | |
| $2.51 | ||
| SMA 50 vs Price | +22.23% | |
| 2.17 | ||
| $0.34 | ||
| 35.09 | ||
| 64.43% | ||
| 90.86% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.06 | ||
| $0.00 | ||
| - | ||
| -$22.49M | ||
| - | ||
| -$22.23M | ||
| - | ||
| -$22.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.05 | ||
| 2.39 | ||
| 2.39 | ||
| - | ||
| - | ||
| -15.22 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 12.96 | ||
| -1.89 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $7.92M | ||
| $13.16M | ||
| $14.04M | ||
| $13.64M | ||
| $6.11M | ||
| $5.71M | ||
| $405.00K | ||
| $0.00 | ||
| $1.52M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $22.23M | ||
| $22.49M | ||
| $0.00 | ||
| $12.20M | ||
| - | ||
| $0.00 | ||
| $800.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$19.21M | ||
| $0.00 | ||
| $23.72M | ||
| $0.00 | ||
| -$19.21M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| B. Riley Securities | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with ACTU
FAQ
What is the ticker symbol for Actuate Therapeutics, Inc. Common stock?
The ticker symbol for Actuate Therapeutics, Inc. Common stock is NASDAQ:ACTU
Does Actuate Therapeutics, Inc. Common stock pay dividends?
No, Actuate Therapeutics, Inc. Common stock does not pay dividends
What sector is Actuate Therapeutics, Inc. Common stock in?
Actuate Therapeutics, Inc. Common stock is in the Healthcare sector
What industry is Actuate Therapeutics, Inc. Common stock in?
Actuate Therapeutics, Inc. Common stock is in the Biotechnology industry
What country is Actuate Therapeutics, Inc. Common stock based in?
Actuate Therapeutics, Inc. Common stock is headquartered in United States
When did Actuate Therapeutics, Inc. Common stock go public?
Actuate Therapeutics, Inc. Common stock initial public offering (IPO) was on August 13, 2024
Is Actuate Therapeutics, Inc. Common stock in the S&P 500?
No, Actuate Therapeutics, Inc. Common stock is not included in the S&P 500 index
Is Actuate Therapeutics, Inc. Common stock in the NASDAQ 100?
No, Actuate Therapeutics, Inc. Common stock is not included in the NASDAQ 100 index
Is Actuate Therapeutics, Inc. Common stock in the Dow Jones?
No, Actuate Therapeutics, Inc. Common stock is not included in the Dow Jones index
When was Actuate Therapeutics, Inc. Common stock last earnings report?
Actuate Therapeutics, Inc. Common stock's most recent earnings report was on May 15, 2026
When does Actuate Therapeutics, Inc. Common stock report earnings?
The next expected earnings date for Actuate Therapeutics, Inc. Common stock is August 13, 2026
Data Sources & References
- ACTU Official Website actuatetherapeutics.com
- ACTU Profile on Yahoo Finance finance.yahoo.com/quote/ACTU
- ACTU Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/actu